Vi bygger
Sveriges bästa private banking

On Monday, 21 October 2024, Bluefront Equity announced the acquisition of Cryogenetics AS (“Cryogenetics”), a leading company within cryopreservation and reproductive technologies for aquaculture. Investinor will continue as a shareholder, supporting the company’s future growth and development together with Bluefront Equity.

ABG Sundal Collier acted as the exclusive financial adviser to the sellers, Geno, Investinor and Utstillingsplassen.

Lime Petroleum Holding AS (“Lime Petroleum Holding”) holds a 100% stake in Lime Petroleum AS with producing assets on the NCS. In addition, Lime Petroleum has signed an agreement with OKEA to acquire 15% interest in the YME Field, increasing Lime’s ownership from 10% to 25% and net production by 3,500 boepd post-acquisition. The company now holds 28.5 mmboe of 2P reserves and 26.8 mmboe of 2C resources.

The net proceeds from the tap issue will be applied towards corporate purposes of the Group, including development capex on the NCS and working capital.

Following a successful two-day virtual roadshow with investor meetings, the bond issue received notable demand from a diverse group of domestic and international high-quality institutional and private investors.

On Tuesday 15 October 2024, Arctic Seafarm AS («Arctic Seafarm», or the «Company») announced a successful directed private placement toward EMK Capital, Kvarøy Fiskeoppdrett AS and selected other existing shareholders (the “Transaction”).

Following the Transaction, EMK Capital will become the majority owner of Arctic Seafarm. The proceeds from the Transaction are securing the financing need for the first phase of Arctic Seafarm’s land-based aquaculture facility, which has a targeted annual salmon production of approximately 10,000 tonnes (~8,000 tonnes HOG).

The facility is expected to release its first smolt in 2026 and be fully operational in 2027. The company has a strategic partnership with traditional sea-based salmon farmer Kvarøy Fiskeoppdrett AS.

ABG Sundal Collier acted as financial advisor to Arctic Seafarm in connection with the Transaction.

On Friday 11 October 2024, Algiecel announced that it had raised approximately DKK 50m (EUR 6.5m) in equity funding. The company’s innovative microalgae-based technology links carbon capture with biology to reduce emissions and enable a sustainable food and feed system by producing high-value ingredients based on microalgae. After the successful inception of its pilot plant in 2022, Algiecel will use the new funds to scale up to a full-size demonstration plant at Novonesis in Kalundborg scheduled for Q3 2025.

Founded in 2021 and headquartered in Odense, Denmark, Algiecel is a pioneer within biosolutions for decarbonisation. By leveraging Algiecel’s proprietary carbon utilisation technology built into modular photobioreactors, Algiecel enables clients to transform industrial CO₂ into sustainable and nutrient rich ingredients containing protein and omega-3. Algiecel’s high-yield photobioreactor utilises microalgae and photosynthesis to convert captured CO₂ into microalgae biomass, that can be further split into a protein and oil fraction, which will ultimately serve as sustainable substitutes across a variety of application areas such as aquaculture feed, petfood, cosmetics and dietary supplements.

First Camp Group AB (publ), the leading campsite owner and operator in Scandinavia and portfolio company owned by Norvestor, has successfully raised a SEK 2,250m senior secured bond. Net proceeds from the bond issue will be used to refinance the existing bond, finance acquisitions of new campsites and for general corporate purposes. Following the acquisitions, the group will have a pro forma revenue of SEK 1,405m with a pro forma adj. EBITDA of SEK 351m and further sentiment their undisputed #1 position in the Scandinavian camping market. The bond issue received exceptional demand from high quality institutional investors and the transaction was substantially over-subscribed. The senior secured bond issue will have a coupon of 3m Stibor plus 4.75% p.a. and will be listed on Nasdaq Stockholm

On Tuesday 1 October 2024, ABG Sundal Collier acted as sole bookrunner in a sale of approximately 13.4 million shares in Link Mobility (the “Company”), equivalent to 4.5% of the Company. The transaction priced at NOK 22.60 per share, for a total transaction size of NOK 303 million. The seller received these shares as partial settlement of an acquisition by Link Mobility and holds no shares in the Company after the transaction.